CME Group (CME) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
UBS Reiterates Buy on CME Group (CME) Following 2Q
July 29, 2016 8:48 AM EDTUBS reiterated a Buy rating on CME Group (NASDAQ: CME), and raised the price target to $114.00 (from $104.00), following the company's 2Q earnings report. UBS raised FY16 EPS estimates to $4.42 from $4.32, and FY17 to $4.95 from $4.80.
Analyst Alex Kramm commented, "CME shares underperformed following its 2Q release,... More
